Sanara MedTech Inc. (SMTI) Q4 2024 Annual Earnings

SMTI·Reported March 25, 2025·Before market open

Sanara MedTech Inc. reported Q4 2024 revenue of $26.3M, beat analyst consensus of $24.1M by $2.2M. Diluted EPS came in at $-0.18, beat the $-0.19 consensus by $0.01.

Revenue

$26.3Mbeat by $2.2M

Consensus: $24.1M

Diluted EPS

$-0.18beat by $0.01

Consensus: $-0.19

SEC Filings

Earnings release8-K not filed yet

Annual report10-K · 0001641172-25-000632

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q4 2024 Earnings FAQ

Common questions about Sanara MedTech Inc.'s Q4 2024 earnings report.

Sanara MedTech Inc. (SMTI) reported Q4 2024 earnings on March 25, 2025 before market open.

Sanara MedTech Inc. reported revenue of $26.3M and diluted EPS of $-0.18 for Q4 2024.

Revenue beat the consensus estimate of $24.1M by $2.2M. EPS beat the consensus estimate of $-0.19 by $0.01.

You can read the 10-K periodic report (0001641172-25-000632) directly on SEC EDGAR. The filing index links above go to sec.gov.